Lorazepam

CAS 846-49-1 10 current records 4 historicalSmall Molecule

Who holds supplier records for Lorazepam? 10 organisations hold a current record for Lorazepam: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (2) and Germany (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Lorazepam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lorazepam

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Lorazepam expires 8 Jan 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lorazepam. Country is the organisation's recorded country, not necessarily the manufacturing site.

India5Italy2Germany1Country not recorded for 2
Need Lorazepam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Lorazepam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CAMBREX PROFARMACO MILANO S.R.L. PaulloIT
CEP 2008-049 - Rev 03
Lorazepam
Jul 2026Inspected Sept 2025
Italy
LAKE CHEMICALS PRIVATE LIMITED BengaluruIN
CEP 2012-113 - Rev 01
Lorazepam, Micronised
Feb 2025—
R L FINE CHEM PVT. LTD. GowribidanurIN
CEP 2010-217 - Rev 03
Lorazepam
Jan 2024—
CENTAUR PHARMACEUTICALS PRIVATE LIMITED MumbaiIN
CEP 2009-056 - Rev 03
Lorazepam
Oct 2023—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2016-243 - Rev 00
Lorazepam
Dec 2022—
EVONIK OPERATIONS GMBH EssenDE
R1-CEP 2008-142 - Rev 04
Lorazepam
Mar 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Lorazepam are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 19268 · filed Mar 2006
  • India · Inactive DMF 17765 · filed Oct 2004
  • India · Inactive DMF 15156 · filed Nov 2000
  • SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENT
    Inactive DMF 5747 · filed Mar 1985

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (41 listed products contain Lorazepam). The latest listed patent expires 8 Jan 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Lorazepam is a benzodiazepine used to treat anxiety disorders, insomnia, and is used as a premedication for sedation. It works by increasing the activity of a certain neurotransmitter in the brain.

Chemical identity

IUPAC name
7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one
Canonical SMILES
C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
InChIKey
DIWRORZWFLOCLC-UHFFFAOYSA-N
Synonyms
Ativan API, lorazepam, Ativan, Temesta, Loraz, Wypax, Almazine, Anxiedin, Lorabenz, Orfidal, Lorazepam Intensol, Wy-4036

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Benzodiazepine
Chemical structure
Benzodiazepines

Therapeutic areas

AnxietyInsomniaSeizure Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lorazepam?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Lorazepam: CAMBREX PROFARMACO MILANO SRL (Italy), CENTAUR PHARMACEUTICALS PVT LTD (India), EVONIK OPERATIONS GMBH (Germany), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), KALINTIS HEALTHCARE PVT LTD (India), MALLADI DRUGS AND PHARMACEUTICALS LTD (India), R.L.FINE CHEM PRIVATE LIMITED (India) and STHREE CHEMICALS PRIVATE LTD, and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lorazepam Drug Master Files are active?

CAMBREX PROFARMACO MILANO SRL (DMF 4517), CENTAUR PHARMACEUTICALS PVT LTD (DMF 22460), EVONIK OPERATIONS GMBH (DMF 5041), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 5027), KALINTIS HEALTHCARE PVT LTD (DMF 35299), MALLADI DRUGS AND PHARMACEUTICALS LTD (DMF 23247), R.L.FINE CHEM PRIVATE LIMITED (DMF 19006) and STHREE CHEMICALS PRIVATE LTD (DMF 40754). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Lorazepam records mean?

4 organisations have only inactive Type II DMFs for Lorazepam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Lorazepam have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Lorazepam on the EDQM register, including CAMBREX PROFARMACO MILANO S.R.L. Paullo (IT), LAKE CHEMICALS PRIVATE LIMITED Bengaluru (IN), R L FINE CHEM PVT. LTD. Gowribidanur (IN), CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai (IN), F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore (IT) and EVONIK OPERATIONS GMBH Essen (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Lorazepam?

Yes. The latest patent listed for an approved US product containing Lorazepam expires 8 Jan 2034, across 41 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Lorazepam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lorazepam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.